Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-4
|
pubmed:dateCreated |
1989-11-9
|
pubmed:abstractText |
Tumor marker serum levels of 580 patients in different stages of breast cancer were examined in a retrospective analysis. Patients with nonmetastatic breast cancer showed a preoperatively elevated CA 15-3 in 16% and an elevation of CEA in 12%. In case of local recurrence in 24% CA 15-3- and in 9% CEA-levels were positive. The sensitivity of both markers increased in stage of distant metastasis (58%/48%). CA 15-3 was significantly more sensitive than CEA in case of visceral metastatic spread (56%/34%).
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0932-0067
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
245
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
674-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2802753-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:2802753-Breast Neoplasms,
pubmed-meshheading:2802753-Carcinoembryonic Antigen,
pubmed-meshheading:2802753-Female,
pubmed-meshheading:2802753-Humans,
pubmed-meshheading:2802753-Neoplasm Metastasis,
pubmed-meshheading:2802753-Neoplasm Recurrence, Local,
pubmed-meshheading:2802753-Prognosis,
pubmed-meshheading:2802753-Tumor Markers, Biological
|
pubmed:year |
1989
|
pubmed:articleTitle |
[The value of tumor markers CA 15-3 and CEA in breast cancer].
|
pubmed:affiliation |
Universitätsfrauenklinik Hamburg.
|
pubmed:publicationType |
Journal Article,
English Abstract
|